Nutrients and Supplements That May Help Ease OCD Symptoms
A new narrative review identifies key nutritional deficiencies in OCD and supplements that may offer safe adjunctive relief.
Summary
A 2026 narrative review synthesizes evidence on how dietary supplements affect obsessive-compulsive disorder (OCD). Researchers searched PubMed, EMBASE, and Scopus for clinical and animal studies on nutrient interventions in OCD. They found that homocysteine, glutamate, vitamin B12, vitamin E, and zinc levels consistently differ between OCD patients and healthy controls, suggesting roles as biomarkers. Supplementation with vitamins C, B6, B9, B12, E, zinc, and N-acetylcysteine showed preliminary benefits for symptom reduction, likely via anti-inflammatory and antioxidant mechanisms. While findings are promising, study heterogeneity, small sample sizes, and inconsistent dosing limit firm conclusions.
Detailed Summary
Obsessive-compulsive disorder (OCD) affects millions worldwide and remains incompletely controlled by standard pharmacotherapy alone. Growing interest in the nutritional underpinnings of psychiatric conditions has prompted researchers to examine whether dietary supplements could serve as safe adjuncts to conventional OCD treatment.
This 2026 narrative review, conducted by Iranian and Chinese researchers, synthesized evidence from clinical trials and relevant animal studies identified across PubMed, EMBASE, and Scopus without date restrictions, culminating in a June 2025 search. The review covered a broad array of nutritional and neurochemical agents, including B vitamins, vitamins C, D, and E, minerals such as zinc, magnesium, selenium, iron, and calcium, as well as amino acid derivatives like glycine and N-acetylcysteine, omega-3 fatty acids, inositol, D-cycloserine, and selected neuromodulators.
Key findings showed that OCD patients consistently display elevated homocysteine and glutamate levels alongside lower concentrations of vitamin B12, vitamin E, and zinc compared to healthy controls. These patterns suggest these markers may serve both as diagnostic biomarkers and therapeutic targets. Preliminary clinical evidence further indicates that supplementing with vitamins C, B6, B9, B12, E, zinc, and N-acetylcysteine can contribute to measurable symptom improvement.
The proposed mechanisms center on anti-inflammatory and antioxidant pathways, which aligns with the broader understanding that neuroinflammation and oxidative stress play roles in OCD pathophysiology. Some pharmacologic neuromodulators, including gabapentin and serotonin-targeting agents, were also reviewed in the nutritional context.
Despite these encouraging signals, the authors caution that significant heterogeneity across study designs, small sample sizes, and variable dosing protocols prevent definitive clinical recommendations. Well-powered, standardized trials are needed to establish optimal supplement types, doses, and treatment durations before widespread clinical adoption.
Key Findings
- Homocysteine, glutamate, vitamin B12, vitamin E, and zinc levels consistently differ between OCD patients and healthy controls.
- Supplementation with vitamins C, B6, B9, B12, E, and zinc shows preliminary symptom improvement in OCD.
- N-acetylcysteine demonstrated notable adjunctive benefit, likely through antioxidant and glutamate-modulating pathways.
- Anti-inflammatory and antioxidant mechanisms appear central to how nutrients may alleviate OCD symptoms.
- Study heterogeneity and small sample sizes prevent definitive dosing or clinical recommendations at this time.
Methodology
This is a narrative review drawing on PubMed, EMBASE, and Scopus searches completed in June 2025 with no publication date restrictions. Both clinical investigations and relevant animal studies were included, selected based on nutrient interventions and OCD-related outcomes. No formal meta-analysis or PRISMA-guided systematic methodology was reported.
Study Limitations
As a narrative rather than systematic review, selection bias and lack of quantitative synthesis limit the strength of conclusions. Most underlying studies had small sample sizes and heterogeneous dosing protocols, making it difficult to determine optimal supplementation strategies. Animal study data were included, which may not directly translate to human OCD presentations.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: